Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene encodes a **pseudogene similar to part of Carboxypeptidase D (CPD)**. Pseudogenes are DNA sequences that resemble known genes but typically contain mutations, insertions, or deletions that prevent them from encoding a functional protein[1][9][7]. While some pseudogenes are transcribed and may regulate gene expression at the RNA level, the majority do not have characterized biological roles. ENSG00000231353 is homologous to the functional CPD gene—which encodes carboxypeptidase D, a regulatory B-type metallocarboxypeptidase involved in peptide hormone biosynthesis and protein processing[2][4][8]—but lacks functionality itself. There is no current evidence for any disease association, clinical utility, or role as a drug or biomarker target, and no interacting drugs are known.
Not applicable; not a protein-coding gene, enzyme, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of Carboxypeptidase D (None).